Mercaptopurine metabolite levels are predictors of bone marrow toxicity following high-dose methotrexate therapy of childhood acute lymphoblastic leukaemia
Crossref DOI link: https://doi.org/10.1007/s00280-015-2717-8
Published Online: 2015-03-19
Published Print: 2015-05
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Vang, Sophia Ingeborg
Schmiegelow, Kjeld
Frandsen, Thomas
Rosthøj, Susanne
Nersting, Jacob
Text and Data Mining valid from 2015-03-19